英国 -
英文 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
kuvan 100mg soluble tablets
biomarin europe ltd - sapropterin dihydrochloride - soluble tablet - 100mg
英国 -
英文 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
firdapse 10mg tablets
biomarin europe ltd - amifampridine phosphate - tablet - 10mg
英国 -
英文 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
vimizim 5mg5ml concentrate for solution for infusion vials
biomarin europe ltd - elosulfase alfa - solution for infusion - 1mg/1ml
英国 -
英文 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
brineura 150mg5ml solution for infusion vials
biomarin europe ltd - cerliponase alfa - solution for infusion - 30mg/1ml
新西兰 -
英文 -
Medsafe (Medicines Safety Authority)
aldurazyme
pharmacy retailing (nz) ltd t/a healthcare logistics - laronidase 0.58 mg/ml (rch) - concentrate for infusion - 500 u/5ml - active: laronidase 0.58 mg/ml (rch) excipient: dibasic sodium phosphate monohydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection
新西兰 -
英文 -
Medsafe (Medicines Safety Authority)
vimizim
pharmacy retailing (nz) ltd t/a healthcare logistics - elosulfase alfa 1 mg/ml; - concentrate for injection - 1 mg/ml - active: elosulfase alfa 1 mg/ml excipient: arginine hydrochloride monobasic sodium phosphate monohydrate polysorbate 20 sodium acetate trihydrate sorbitol water for injection - treatment of mucopolysaccharidosis type iva (mps iva; morquio a syndrome) in children and adults of all ages.
以色列 -
英文 -
Ministry of Health
naglazyme
medison pharma ltd - galsulfase - concentrate for solution for infusion - galsulfase 1 mg/ml - galsulfase - galsulfase - naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mpsvi (n-acetylglactosamine 4 sulfatase deficiency maroteaux-lamy syndrome).
澳大利亚 -
英文 -
Department of Health (Therapeutic Goods Administration)
kuvan
merck serono australia pty ltd - sapropterin dihydrochloride -
菲律宾 -
英文 -
FDA (Food And Drug Administration)
aldurazyme 580 mcg/ml (2.9 mg/5 ml) concentrated solution for iv infusion
n/a; importer: sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - laronidase - concentrated solution for iv infusion - 580 mcg/ml (2.9 mg/5 ml)
加拿大 -
英文 -
Health Canada
aldurazyme solution
sanofi genzyme, a division of sanofi-aventis canada inc - laronidase - solution - 0.58mg - laronidase 0.58mg - enzymes